Novanta Inc. (LON:0VAG)
Market Cap | 3.01B |
Revenue (ttm) | 697.75M |
Net Income (ttm) | 44.74M |
Shares Out | n/a |
EPS (ttm) | 1.23 |
PE Ratio | 67.27 |
Forward PE | 32.14 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 36 |
Average Volume | 47 |
Open | 116.60 |
Previous Close | 117.44 |
Day's Range | 115.38 - 117.00 |
52-Week Range | 100.22 - 183.06 |
Beta | 1.29 |
RSI | 46.22 |
Earnings Date | Nov 4, 2025 |
About Novanta
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision... [Read more]
Financial Performance
In 2024, Novanta's revenue was $949.25 million, an increase of 7.67% compared to the previous year's $881.66 million. Earnings were $64.09 million, a decrease of -12.06%.
Financial numbers in USD Financial StatementsNews

Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...

Novanta (NOVT) Q2 Revenue Rises 2.2%
Novanta Inc. (NOVT) Q2 2025 Earnings Call Transcript
Novanta Non-GAAP EPS of $0.76 beats by $0.03, revenue of $241M beats by $3.03M

Novanta Announces Financial Results for the Second Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial res...

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 resu...

Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chie...

Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chie...

Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...
Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript
Novanta Announces Financial Results for the First Quarter 2025
First Quarter 2025 GAAP Revenue increased 1% to $233 million First Quarter 2025 GAAP Diluted Earnings Per Share of $0.59 and Adjusted EPS of $0.74 First Quarter 2025 GAAP Net Income increased 45% to $...

Novanta Announces Financial Results for the First Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial res...

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 20...
Novanta: A Trusted Yet Premium Technology Partner
Decoding Novanta Inc (NOVT): A Strategic SWOT Insight
Decoding Novanta Inc (NOVT): A Strategic SWOT Insight
Novanta files for automatic mixed securities shelf
Novanta Inc. (NOVT) Q4 2024 Earnings Call Transcript
Novanta Inc (NOVT) Shares Up 5.71% on Feb 25
Novanta Inc (NOVT) Shares Up 5.71% on Feb 25
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024
Fourth Quarter 2024 GAAP Revenue increased 13% to $238 million, including $2 million unfavorable FX impact Fourth Quarter 2024 GAAP Diluted EPS of $0.46 and Adjusted EPS of $0.76 Full Year 2024 GAAP R...

Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported finan...

Earnings Scheduled For February 25, 2025
Companies Reporting Before The Bell • Super Group (SGHC) (NYSE: SGHC) is estimated to report earnings for its fourth quarter. • Carter's (NYSE: CRI) is expected to report quarterly earnings at $1.90...
Novanta Q4 2024 Earnings Preview

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter a...
Novanta: Delayed Recovery And Prolonged Struggles Ahead, Downgrade To Sell
Novanta Inc (NOVT) to Participate in CJS Securities Investor Conference
Novanta Inc (NOVT) to Participate in CJS Securities Investor Conference